SBC

SBC Medical Group

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 100%
Negative

Neutral
Business Wire
4 days ago
SBC Medical Announces Opening of Brand Flagship "NEO Skin Clinic Ginza."
IRVINE, Calif.--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced that its specialized aesthetic brand, “NEO Skin Clinic,” will open its flagship location in Tokyo's Ginza district, a globally recognized medical tourism hub and highly competitive district, on Saturday, March 28, 2026. The Ginza flagship, located i.
SBC Medical Announces Opening of Brand Flagship "NEO Skin Clinic Ginza."
Neutral
GlobeNewsWire
7 days ago
SBC Medical to Announce Q4 and Full‑Year 2025 Financial Results
IRVINE, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced it will release its financial results for the fourth quarter and fiscal year ended December 31, 2025, before U.S. market open on March 27, 2026.
SBC Medical to Announce Q4 and Full‑Year 2025 Financial Results
Neutral
Business Wire
18 days ago
SBC Medical Appoints Sheng-FU Hsiao as CTO Leveraging Medical Big Data from 283 Global Locations and 6.63 Million Annual Patient Visits to Build a Scalable, AI-Driven Medical Management Infrastructure
IRVINE, Calif.--(BUSINESS WIRE)-- #AI--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced the appointment of Sheng-FU Hsiao as Chief Technology Officer (CTO), effective March 1, 2026. This appointment aligns with the Company's 2026 management strategy, "Sophistication of Management Structure through AI and DX," and strengthens its leader.
SBC Medical Appoints Sheng-FU Hsiao as CTO Leveraging Medical Big Data from 283 Global Locations and 6.63 Million Annual Patient Visits to Build a Scalable, AI-Driven Medical Management Infrastructure
Neutral
PRNewsWire
1 month ago
SBC Medical-Supported Medical Corporation Nasukai Forms Strategic Alliance with Daibi Medical Aesthetics
Alliance to Enhance Shonan Beauty Clinic Brand Recognition in China and Support Growth in Inbound Medical Demand to Japan IRVINE, Calif., Feb. 1, 2026 /PRNewswire/ -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced that Medical Corporation Nasukai, a Japan-based medical corporation supported by SBC Medical and the operator of Shonan Beauty Clinic, has entered into a strategic business alliance with Daibi Medical Aesthetics, a medical aesthetic clinic based in Shanghai, China.
SBC Medical-Supported Medical Corporation Nasukai Forms Strategic Alliance with Daibi Medical Aesthetics
Neutral
Accesswire
2 months ago
Emerging Growth Research Maintains Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Strategic U.S. Market Entry
NEW YORK, NY / ACCESS Newswire / January 7, 2026 / Emerging Growth Research today announced the release of its Flash Report on SBC Medical Group Holdings, Inc. (Nasdaq:SBC), maintaining a Buy-Extended rating and its 12-month price target of $9.00, representing significant upside from the Company's closing price of $4.44 on January 6, 2026. The Flash Report highlights SBC's major milestone entry into the United States medical aesthetics market through a strategic minority equity investment and structured collaboration framework with OrangeTwist, a leading U.S.-based MedSpa chain.
Emerging Growth Research Maintains Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Strategic U.S. Market Entry
Neutral
Business Wire
2 months ago
OrangeTwist Announces Strategic Alliance with SBC Medical Group Holdings and Expansion to 24 Locations Across 6 States to Support Long-Term Growth Initiatives
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--OrangeTwist, a leading U.S. med spa platform delivering cutting-edge aesthetic and wellness treatments through a hospitality-driven clinical experience, has announced a strategic alliance and minority investment with SBC Medical Group Holdings Incorporated (Nasdaq: SBC) as part of its accelerated national growth strategy. The collaboration marks a significant milestone for OrangeTwist, enabling new clinical, operational, and technological synergies with a.
OrangeTwist Announces Strategic Alliance with SBC Medical Group Holdings and Expansion to 24 Locations Across 6 States to Support Long-Term Growth Initiatives
Neutral
Business Wire
2 months ago
SBC Medical Accelerates Global Expansion with Strategic Investment and Alliance with a Leading U.S. MedSpa Platform OrangeTwist as Part of Broader Growth Strategy
IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--SBC Medical has entered into a Memorandum of Understanding (MoU) for capital investment and strategic alliance with OrangeTwist.
SBC Medical Accelerates Global Expansion with Strategic Investment and Alliance with a Leading U.S. MedSpa Platform OrangeTwist as Part of Broader Growth Strategy
Neutral
Business Wire
3 months ago
SBC Medical Group Holdings: Announcement of Final Results of Tender Offer for Waqoo, Inc. Shares
TOKYO--(BUSINESS WIRE)-- #Healthcare--The final results of its tender offer for common shares of Waqoo, Inc. (TOKYO:4937).
SBC Medical Group Holdings: Announcement of Final Results of Tender Offer for Waqoo, Inc. Shares
Neutral
Newsfile Corp
3 months ago
Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q3:25 Results
New York, New York--(Newsfile Corp. - December 1, 2025) - Emerging Growth Research today announced the release of its Q3:25 quarterly update on SBC Medical Group Holdings, Inc. (NASDAQ: SBC), reiterating a Buy-Extended rating and maintaining its 12-month price target of $9.00, representing significant upside from the Company's recent closing price of $3.57 on November 28, 2025. The quarterly update highlights SBC's sequential stabilization in revenue and operating profit during Q3:25, strong cash position, and the Company's positioning for renewed growth beginning in early 2026 as it works through near-term competitive pressures.
Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q3:25 Results
Neutral
Business Wire
4 months ago
SBC Medical Group Enters the Thai Market through Partnership with BLEZ
IRVINE, Calif.--(BUSINESS WIRE)-- #Medical--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that it has entered into a Consulting Agreement with BLEZ ASIA Co., Ltd. (Headquarters: Bangkok, Thailand; CEO: Naoki Iida; “BLEZ”), which operates more than 20 pharmacies and clinics in Thailand and is widely trusted by both Japanese expatriate.
SBC Medical Group Enters the Thai Market through Partnership with BLEZ